Tevogen Inc. Increase Decrease In Operating Lease Liability
Tevogen Inc. (TVGN) reported Increase Decrease In Operating Lease Liability of -$58.66 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- Tevogen Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$29.88K.
- Tevogen Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$28.78K.
- Tevogen Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$27.73K.
- Tevogen Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$26.71K.
- Tevogen Inc. increase decrease in operating lease liability for fiscal 2025 was -$297.98K.
- Tevogen Inc. increase decrease in operating lease liability for fiscal 2024 was -$252.71K.
- Tevogen Inc. increase decrease in operating lease liability for fiscal 2023 was -$223.36K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$58.66K 10-Q · filed 2026-08-14 | -$86.38K derived: sum of 3 quarters · filed 2026-08-14 | -$113.09K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$28.78K 10-Q · filed 2026-05-15 | -$56.51K derived: sum of 2 quarters · filed 2026-05-15 | -$83.21K derived: sum of 3 quarters · filed 2026-05-15 | -$262.75K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$27.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$54.43K derived: sum of 2 quarters · filed 2026-03-31 | -$233.97K derived: sum of 3 quarters · filed 2026-08-14 | -$297.98K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$26.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$206.24K derived: sum of 2 quarters · filed 2026-08-14 | -$270.25K 10-Q · filed 2025-11-14 | -$336.46K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$179.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$243.54K 10-Q · filed 2026-08-14 | -$309.76K derived: sum of 3 quarters · filed 2026-08-14 | -$374.17K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$64.01K 10-Q · filed 2026-05-15 | -$130.22K derived: sum of 2 quarters · filed 2026-05-15 | -$194.63K derived: sum of 3 quarters · filed 2026-05-15 | -$256.52K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$66.21K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$130.62K derived: sum of 2 quarters · filed 2026-03-31 | -$192.51K derived: sum of 3 quarters · filed 2026-03-31 | -$252.71K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$64.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$126.30K derived: sum of 2 quarters · filed 2025-11-14 | -$186.50K 10-Q · filed 2025-11-14 | -$248.18K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$61.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$122.09K 10-Q · filed 2025-08-14 | -$183.77K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$60.20K 10-Q · filed 2025-05-14 | -$121.88K derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$61.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | -$223.36K 10-K · filed 2025-04-02 | ||
| 2023-09-30 | -$161.68K 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |